Literature DB >> 17574682

Method to perform IV injections on mice using the facial vein.

H B Levene1, M Zhang, C J Erb, J I Jallo, C M Loftus, R F Tuma.   

Abstract

A novel technique for gaining IV access in a mouse model is presented. Using a cut-down approach, the facial vein is identified through an incision from anterior to the external auditory meatus to posterior to the lateral ispilateral canthus. A small gage needle (30gauge) may be inserted to inject medications. A high success rate (93%) as determined by direct visualization is achieved. The technique would prove especially useful for animals slated for kinematic testing as the incision does not interfere with the animal's ventral surface.

Entities:  

Mesh:

Year:  2007        PMID: 17574682     DOI: 10.1016/j.jneumeth.2007.05.007

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  4 in total

1.  IV and IP administration of rhodamine in visualization of WBC-BBB interactions in cerebral vessels.

Authors:  Zachary Wilmer Reichenbach; Hongbo Li; John P Gaughan; Melanie Elliott; Ronald Tuma
Journal:  Microsc Res Tech       Date:  2015-07-24       Impact factor: 2.769

2.  Deficiency of PAR4 attenuates cerebral ischemia/reperfusion injury in mice.

Authors:  Yingying Mao; Ming Zhang; Ronald F Tuma; Satya P Kunapuli
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-20       Impact factor: 6.200

3.  CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury.

Authors:  Ming Zhang; Martin W Adler; Mary E Abood; Doina Ganea; Jack Jallo; Ronald F Tuma
Journal:  Microvasc Res       Date:  2009-03-28       Impact factor: 3.514

4.  Assessment of the Therapeutic Potential of Metallothionein-II Application in Focal Cerebral Ischemia In Vitro and In Vivo.

Authors:  Abass Eidizadeh; Manuel Khajehalichalehshtari; Dorette Freyer; George Trendelenburg
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.